The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of higher PD-L1 expression in tumor cells of metastatic ccRCC lesions with worse overall survival.
 
Kathleen Margaret Mahoney
No Relationships to Disclose
 
Ritesh R. Kotecha
No Relationships to Disclose
 
Marcella Callea
No Relationships to Disclose
 
Opeyemi Jegede
No Relationships to Disclose
 
Paul J. Catalano
Research Funding - Lilly/ImClone
 
Jiaxi Song
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Guillermo de Velasco
Employment - GlaxoSmithKline (I)
 
Hilla Conen
No Relationships to Disclose
 
Alexander Carlson
No Relationships to Disclose
 
Craig Norton
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
M Dror Michaelson
Employment - Jounce Therapeutics (I)
Consulting or Advisory Role - Astellas Pharma; Medivation; Millennium; Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Eisai (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Mamta Gupta
No Relationships to Disclose
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Gordon J. Freeman
Stock and Other Ownership Interests - Novartis; Novartis (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Novartis (I); Roche/Genentech; Surface Oncology (I)
Patents, Royalties, Other Intellectual Property - Amplimmune/Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; EMD Serono; Merck; Novartis; Novartis (I); Pfizer (I); Roche/Genentech; Roche/Genentech (I)
 
Rupal Satish Bhatt
No Relationships to Disclose
 
Sabina Signoretti
No Relationships to Disclose